Skip to main content

Table 1 Characteristics of study population by HAART status at Burayu Health center, Addis Ababa, Ethiopia, 2012

From: Antiretroviral treatment associated hyperglycemia and dyslipidemia among HIV infected patients at Burayu Health Center, Addis Ababa, Ethiopia: a cross-sectional comparative study

Variable

HAART initiated (n=126)

Non-HAART (n=126)

N (%)

N (%)

Gender

Female

86(68.3)

96(76.2)

Male

40(31.7)

30(23.8)

Age group (years)

Mean ± SD

37.1(9.8)

33.4(10.2)

18-29

25(19.8)

51(40.5)**

30-39

61(48.4)

49(38.9)

40-49

25(19.8)

16(12.7)

≥50

15(11.9)

10(7.9)

BMI

Mean ± SD

21.9(3.2)

20.8(2.8)

<18.5

9(7.1)

24(19)*

18.5-24.9

97(77)

91(72.2)

25-29.9

17(13.5)

10(7.9)

≥30

3(2.4)

1(0.8)

CD4+ cells (cells/mm3)

Mean ± SD

314.5 ± 152.5

413.6 ± 246.2

<200

34(27)

25(19.8)**

200-400

58(46)

42(33.3)

>400

34(27)

59(46.8)

Duration of HIV infection (month)

Mean ± SD

29.5(17)

11.8(12.3)

<6

0(0)

57(45.2)***

6-12

22(17.5)

21(16.7)

13-24

22(17.5)

27(21.4)

25-41

59(46.8)

19(15.1)

≥42

23(18.3)

2(1.6)

TB Co-infection

Present

21(16.7)

18(14.3)

Not present

105(83.3)

108(85.7)

  1. N, number; BMI, body mass index; HAART, highly active antiretroviral therapy; TB, tuberculosis; SD, standard deviation; *p-value =0.02; **p-value =0.004; ***p-value <0.0001.